Kiadis Pharma

Kiadis Pharma N.V.
Stock Exchange Euronext - Alternext Amsterdam
EPS
EUR1.46
Market Cap
EUR175.91 M
Shares Outstanding
29.56 M
Public Float
16.61 M
Kiadis Pharma N.V.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
20.12 M
Public Float
-

Profile

Address
Paasheuvelweg 25
Amsterdam Noord-Holland 1105 BP
Netherlands
Employees -
Website http://www.kiadis.com
Updated 07/08/2019
Kiadis Pharma NV is a clinical stage biopharmaceutical company. It engages in the research, development, and future commercialization of cell-based immunotherapy products for treatment of blood cancers and inherited blood disorders. The company provide the products for Allodepleted T-cell ImmunotheRapeutics that are based on its theralux platform.

Financials

View All

Mark A. Wegter
Chairman-Supervisory Board
Subhanu Saxena
Member-Supervisory Board